Company Profile
Nemaura Medical Stock Price, News & Analysis
- Ticker:
- NMRD
- Exchange:
- PINK
- Sector:
- Biopharma
- Location:
- United Kingdom and trades in the U
Stock performance
0.00 USD (-99.00%)
Close
Last updated: August 4, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for NMRD.
Company overview
Business overview
Nemaura Medical is a healthcare technology company focused on noninvasive glucose monitoring and chronic-disease management tools. Its story is built around the promise of sensor-based monitoring without traditional finger-stick workflows.
Geographic Base and Sector Classification
Nemaura Medical is headquartered in the United Kingdom and trades in the U.S. market. It sits in medical technology and digital health rather than biotech therapeutics.
Business Model Characteristics
The business depends on product adoption, commercialization, and the ability to translate noninvasive monitoring into recurring usage. Investors focus on device rollout, reimbursement, and execution more than on drug-development catalysts.
Position Within the Biotechnology Landscape
Nemaura sits in the chronic-care device and digital-monitoring layer of healthcare. It is not biotech proper, but it belongs to the broader health-tech stack where adoption and reimbursement matter most.
Future catalysts
Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction. The company needs more visible adoption.
Recent news
- 01
Important Update on Listing Status and Strategic Direction
Source: Nemaura Medical
- 02
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
Source: Nemaura Medical
- 03
- 04
- 05
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
Source: Nemaura Medical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nemaura Medical (NMRD)?
Nemaura Medical (NMRD) most recently closed at 0.00 USD, a -99.00% move versus the previous session.
What does Nemaura Medical do?
Nemaura Medical is a healthcare technology company focused on noninvasive glucose monitoring and chronic-disease management tools. Its story is built around the promise of sensor-based monitoring without traditional finger-stick workflows.
On which exchange is NMRD stock listed?
Nemaura Medical (NMRD) is associated with PINK, United Kingdom and trades in the U, Biopharma.
What is Nemaura?
Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction.
Which conditions is Nemaura Medical targeting with Nemaura?
Nemaura Medical is associated with metabolic disease, diabetes based on its company overview and current catalyst commentary.
How does Nemaura Medical describe recent progress with Nemaura?
Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction.
What is Medical?
Nemaura Medical is a healthcare technology company focused on noninvasive glucose monitoring and chronic-disease management tools.
What should investors watch for with Medical?
Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction.